Prologue — When Mental Health Became Infrastructure
Six years have passed since COVID-19 in 2020, but the shock has not faded — it has accumulated. According to the WHO, depression cases worldwide rose 25 % in the first year of the pandemic, and that number has not come down by 2026.
The bottleneck is supply. In the US, the ratio of patients to a single clinical psychologist or psychiatrist is 350:1; in Korea about 1,200 per doctor, in Japan about 850. Night and weekend access is nearly impossible, and the wait for an appointment averages 4-12 weeks.
Two things happened simultaneously here.
- The rise of LLMs — ChatGPT and Claude became a free 24-hour "someone who listens."
- The maturing of dedicated chatbots — Woebot, Wysa, and Earkick ported CBT (cognitive behavioral therapy) and DBT (dialectical behavior therapy) models onto chatbot interfaces.
As of May 2026 the picture, summarized in one sentence per category:
- CBT-only chatbots — Woebot, Wysa, and Iris attempt to port clinically validated techniques to a chatbot.
- Consumer AI companions — Replika, Character.AI, and Pi simulate "friends and lovers." Crisis response is lacking.
- Meditation + AI integration — Headspace (Ebb) and Calm have begun layering AI coaches on top of guided meditation.
- Enterprise EAP — Lyra Health, Spring Health, and Modern Health offer human + AI bundles via company insurance.
- Telehealth — Talkspace and BetterHelp added AI triage on top of human-therapist matching.
- Crisis lines — 988 (US) and Trevor Project are piloting AI-assisted technology.
This essay ties together the clinical evidence, pricing, risks, and Korea/Japan landscape for those 50-plus tools in a single flow.
Chapter 1 · Why AI Mental Health Is Needed
Before adopting the technology, you have to look at demand. The four axes of the 2026 mental health crisis.
- Therapist shortage — SAMHSA estimates roughly 110,000 clinical psychologists and about 40,000 psychiatrists in the US. For a population of 340 million, an absolute shortage.
- Stigma — In Korea, Japan, and Southeast Asia, the act of "going to a psychiatrist" itself carries a social cost. An anonymous chatbot lowers the first barrier to entry.
- Access — Rural areas, nights, weekends. Human therapists are rarely available outside 9 a.m.-6 p.m. Chatbots answer at 3 a.m.
- Cost — 100-200 USD per session in the US, 50,000-150,000 KRW in Korea, 5,000-15,000 JPY in Japan. Insurance coverage is limited.
The core value of AI chatbots is not "replacing expert care" but "first entry and daily management." Crises must still go to human experts.
[The 5 stages of mental health care — 2026 model]
1. Daily monitoring — Mood trackers, journals, meditation apps (Earkick, Calm)
2. Daily coaching — CBT chatbots (Woebot, Wysa)
3. Light counseling — Telehealth + AI triage (Talkspace, BetterHelp)
4. Specialist care — Human clinical psychologists / psychiatrists (1:1)
5. Crisis response — ERs, 988, Korea 1393, Japan #いのちSOS
Each stage is owned by different tools and different people. AI concentrates on stages 1-3; humans take charge of stages 4-5.
Chapter 2 · The Origin of Chatbot Mental Health — From ELIZA (1966) to Woebot
The history of AI chatbot therapy is sixty years long.
- ELIZA (1966) — Joseph Weizenbaum at MIT. Simulated Rogerian non-directive therapy with simple pattern matching. The "Eliza effect" — the phenomenon of users projecting emotions onto the computer — was first observed here.
- PARRY (1972) — A paranoid-patient simulation built by Kenneth Colby.
- Woebot (2017) — Founded by Stanford PhD Alison Darcy. The first CBT-based chatbot.
- Wysa (2016) — India and the UK. An AI penguin character.
- Replika (2017) — Eugenia Kuyda. Started as a friend.
- Earkick (2023) — Karin Stephan. Targeting Gen Z.
In his 1976 book "Computer Power and Human Reason," Weizenbaum wrote that he was shocked to see his own secretary become emotionally dependent on ELIZA. The question he raised 60 years ago — "Is a machine pretending to have feelings helping humans, or harming them?" — came back to life in the 2026 Character.AI lawsuit.
Chapter 3 · Woebot Health — The Glory and Frustration of an FDA Breakthrough Device
Woebot (woebothealth.com) launched in 2017. A CBT chatbot built by Dr. Alison Darcy at Stanford.
- Clinical evidence — A 2017 JMIR Mental Health paper showed a statistically significant drop in PHQ-9 (depression scale) after two weeks of use.
- FDA Breakthrough Device designation (2021) — Adult and Adolescent Depression module.
- FDA Breakthrough Device designation (2022) — Postpartum Depression module.
- B2C shutdown (2024) — Shut down the consumer app. Pivoted to B2B for employers and providers.
Woebot's pivot illustrates the broader troubles of the digital therapeutics (DTx) industry. Pear Therapeutics (reSET, reSET-O) went bankrupt in 2023, and Akili Interactive (EndeavorRx) similarly scaled down around the same time.
There are two problems.
- No insurance codes — A dedicated insurance code (CPT) for DTx was established late in the US.
- Limited clinical effect — In RCTs (randomized controlled trials), the effect size is smaller than or comparable to SSRIs (drugs) or human CBT.
Woebot's academic legacy is large, but it is not an app a regular consumer can download in May 2026.
Chapter 4 · Wysa — Fifty Countries Alongside the NHS
Wysa (wysa.com) started in Bengaluru, India in 2016. The parent company is Touchkin eServices.
- AI penguin — A character design. It gives both familiarity and emotional distance.
- Clinical modules — CBT, DBT, mindfulness, sleep therapy.
- NHS adoption (2022~) — UK National Health Service. Deployed across several ICBs (Integrated Care Boards) such as North East and North Cumbria.
- Singapore government adoption (2023) — Linked with the Healthy 365 app.
- B2B model — Sold as an enterprise EAP (Employee Assistance Program).
Pricing (as of May 2026).
- Individual — Free + 99 USD/year (Premium, includes messages from human coaches).
- Enterprise — Roughly 10-15 USD per employee per month.
Wysa's differentiator is sincerity about clinical evidence. It has more than 50 peer-reviewed papers, and the effect data published at the time of NHS adoption showed statistically significant reductions on depression and anxiety scales.
That said, Korea and Japan are still on the to-do list. Only English, Spanish, Hindi, and Mandarin are supported.
Chapter 5 · Earkick — A Mood Tracker for Gen Z
Earkick (earkick.com) is a new app that launched in 2023. Founded by Karin Stephan and Herbert Bay.
- GPT-backed — Uses the OpenAI API as its backend.
- Mood tracker — Short daily emotion check-ins.
- Voice input emphasized — Gen Z prefers speaking over typing.
- Free — No ads. Premium is also reasonably priced (40 USD/year).
Earkick's secret to popularity is the design. Where other apps adopt a "serious and clinical" tone, Earkick's tone is "a KakaoTalk message from a friend." The characters (Panda and other animals) are friendly and the short replies have emojis.
But the clinical evidence is still thin. There are no peer-reviewed RCTs. The claim is more along the lines of "we partially borrow CBT techniques." Compared to Wysa and Woebot, the clinical credibility is lower.
Chapter 6 · Iris, Tess, Limbic — Other Chatbot Attempts
Smaller but meaningful tools.
- Iris (a virtual-friend-mode chatbot) — Focuses on emotional support. Does not claim to be clinical.
- Tess (X2AI) — Text-based AI. Famous for delivering crisis counseling to Syrian refugees in Lebanon. WhatsApp and SMS channels.
- Limbic Access (UK) — An assessment chatbot at the entry point of NHS Talking Therapies (IAPT). Used for patient triage.
The Tess case matters. It showed that in refugee camps where mental health professionals are nearly inaccessible, an AI chatbot can become a first entry channel. The possibility of "not a developed-country luxury but a necessity for vulnerable populations."
Limbic goes in a different direction. The chatbot runs the assessment patients take before NHS counseling. A B2B tool that saves doctor time and automates triage.
Chapter 7 · Replika — The Ethical Gray Zone of AI Companions
Replika (replika.com) started in 2017. Eugenia Kuyda built it inspired by a chatbot designed to remember a deceased friend.
- Friend / mentor / sibling / lover — The user chooses the relationship mode.
- Paid — Pro 70 USD/year. EROS (erotic roleplay) mode is included with Pro.
- Users — About 25 million (2024 estimate).
The core of the controversy was February 2023. Replika abruptly cut the EROS mode. The reason was an investigation by Italy's data protection authority (Garante). User backlash was strong — pleas like "my lover suddenly became a different person" flooded r/replika.
The company partially restored EROS for some users (those who signed up before February 2023) in late 2023. The concerns of the mental health academic community.
- Dependency risk — One can become addicted to fake intimacy.
- Insufficient crisis detection — Cases reported of failing to respond appropriately to messages like "I want to die."
- EROS and mental health — There is no academic consensus on whether companion chatbots relieve loneliness or amplify it.
A 2025 Cornell-MIT joint study reported that loneliness in heavy users of ChatGPT's voice mode rose over time. It does not apply directly to Replika, but it casts doubt on the assumption that "AI companions reduce loneliness."
Chapter 8 · Character.AI — Fan-Made Therapists and a Teen Suicide Lawsuit
Character.AI (character.ai) was founded in 2022 by Noam Shazeer, a Google alum. Google acquired it in August 2024.
- User-made characters — Anyone can create and share a character.
- Users — About 20 million MAU in 2024.
- Popular categories — Anime characters, celebrities, "psychological therapist" personas.
The incident in question was reported in October 2024. Sewell Setzer, a 14-year-old in Florida, took his own life after months of conversations with Character.AI's "Daenerys Targaryen" character. The family sued Character.AI. The two core claims.
- Failure to recognize warning signs — Even when suicidal intent was stated explicitly, the crisis response messages were inadequate.
- No age verification — Only those under 13 were blocked, and 14-year-old users had access to adult content.
In December 2024, the FTC began investigating AI companion apps including Character.AI. The APA (American Psychological Association) issued an official statement in January 2025 that "it is dangerous for unvalidated AI chatbots to claim to provide clinical treatment."
Character.AI added changes in late 2024 — minor-protection filters, strengthened crisis-response messages, usage-time alerts. But the fundamental problem — the structure where "fan-made, unvalidated therapists are talking to teens in suicidal crisis" — has not been fully resolved.
Chapter 9 · Koko, Replika, and Beyond — The Cluster of AI Companion Chatbots
Other companion chatbots.
- Pi (Inflection AI) — Founded by Mustafa Suleyman (now CEO of Microsoft AI). Soft conversational tone. After Microsoft poached the core team in 2024, the business is effectively wound down.
- Anima — A Replika competitor. Has users in Korea and Japan too.
- Kuki AI — Out of Pandorabots.
- Xiaoice — Started inside Microsoft Research Asia, spun out in 2020. Huge popularity in China and Japan. The Japanese name is Rinna.
- Koko (Rob Morris) — Another case. In January 2023, he disclosed an experiment in which OpenAI's GPT-3 auto-drafted mental-health messages for roughly 4,000 users, triggering an ethical controversy.
The Koko incident has large implications. Users received "peer support" messages without knowing that an AI had written the drafts. Rob Morris (CEO) wrote on Twitter and acknowledged that "once you know an AI wrote it, the message feels impersonal." A case that made the issue of informed consent in AI mental health visible.
Chapter 10 · Mindstrong — The Rise and Fall of Passive Sensing
Mindstrong Health was co-founded in 2014 by Tom Insel (former director of NIMH).
- Core idea — Analyze phone-usage patterns (typing speed, scrolling, app switching) with machine learning to build digital biomarkers for depression and anxiety.
- Funding — Raised 160 million USD through Series C.
- Shutdown — Disbanded after acquisition in February 2023.
Mindstrong's failure is analyzed in two ways. First, the clinical utility of the digital biomarkers was not sufficiently proven. Second, the business model of filling in for the human-therapist shortage got blocked by insurer negotiations.
Other attempts in the same area — passive monitoring like Mindstrong.
- Mood 23andMe — Genetics + mental health risk.
- Cogito — Voice-pattern analysis. Depression-risk detection in call centers.
- Ellipsis Health — Voice-based depression assessment.
This field still has not cleared the two walls of clinical validation and insurance acceptance in 2026.
Chapter 11 · Headspace + Ebb — LLM Integration of Meditation
Headspace (headspace.com) was founded in the UK in 2010 by Andy Puddicombe and Rich Pierson. In 2021 it merged with Ginger to become Headspace Health.
- Users — About 100 million downloads.
- Pricing — 12.99 USD/month or 69.99 USD/year.
- Content — Guided meditation, sleep stories, exercise.
- B2B — A major success with enterprise EAPs. Full employee licenses per company.
In July 2024, Headspace unveiled an AI companion called Ebb. When users share their emotional state through text or voice, Ebb either recommends a short meditation or has a gentle conversation.
Ebb's clinical consultation followed the American Psychological Association's guidelines, and on detecting suicide-risk messages it immediately routes to crisis lines such as 988. Because it launched after the Character.AI incident, it is cautious about crisis response.
Headspace's strength is its content library. AI is positioned strictly as a content guide; the content itself is vetted material created by clinical psychologists and meditation teachers.
Chapter 12 · Calm + Calm AI — AI Atop Sleep Stories
Calm (calm.com) was founded in 2012 by Alex Tew and Michael Acton Smith. In 2019 it became the first mental health unicorn (1 billion USD valuation).
- Pricing — 14.99 USD/month or 69.99 USD/year.
- Content — Guided meditation, sleep stories (narrated by celebrities like Matthew McConaughey and Stephen Fry), nature sounds.
Calm leans on content curation more than Headspace. The 2024-2025 AI integration is on the conservative side. It goes about as far as recommending a fitting meditation when you describe your emotion by voice. It deliberately avoids the kind of free-form conversation Character.AI offers.
Calm's B2B business (Calm Business) is also growing fast. Licenses meditation content to enterprise EAPs.
Chapter 13 · Lyra Health, Spring Health, Modern Health — The Enterprise EAP Big Three
US corporate mental health benefits. Directly provide human-therapist matching plus AI triage to employees.
- Lyra Health — Founded in 2015 by Tom Saunders. Customers include some 200 large enterprises like Salesforce, Morgan Stanley, and eBay. Valued at roughly 4.7 billion USD (2022).
- Spring Health — Founded in 2016 by April Koh. Touts "precision mental healthcare" — user-analytics-based matching. Valued at roughly 3.3 billion USD.
- Modern Health — Founded in 2017 by Alyson Watson. Around 5-15 USD per employee per month. EAP + coaching + human therapists.
All three companies share the stance that "AI is an assistant; humans are the core." Their chatbots do not engage in free-form conversation and concentrate on symptom assessment, matching, and scheduling automation.
From the company side the ROI is clear. When depression and burnout fall, absenteeism and attrition drop. Some studies estimate 3-5 USD saved per 1 USD invested in EAPs.
Chapter 14 · Talkspace, BetterHelp — The Two Telehealth Giants
Talkspace (talkspace.com) was founded in 2012 by Oren Frank. BetterHelp (betterhelp.com) was founded in 2013 by Alon Matas. Became a Teladoc Health subsidiary in 2015.
- Talkspace — Pricing 70-100 USD/week (text), 100-150 USD/week (live video). Partially covered by US Medicare.
- BetterHelp — Pricing 65-95 USD/week. Almost no insurance coverage.
Both companies have introduced AI triage. When the user fills out an intake form, NLP analyzes symptoms, preferences, and prior experience to match the most suitable therapist.
Controversy — for both companies, marketing costs take up 30-40 % of revenue. Massive spend on influencer and YouTube sponsorship. Some critics point out that "mental health has become an advertising industry."
BetterHelp also paid a 7.8 million USD settlement in 2023 over FTC allegations that it shared user data (including symptom information) with Facebook and Snapchat for ad targeting. Using mental health data for advertising is highly controversial even in the US.
Chapter 15 · Crisis Lines + AI — 988, Trevor Project, Vibrant Emotional Health
The US launched the 988 Suicide & Crisis Lifeline on July 16, 2022. It replaced the prior 1-800-273-8255 with the short code 988.
- Operation — Run by Vibrant Emotional Health under a SAMHSA contract.
- Channels — Phone 988, chat 988lifeline.org, text 988.
- 2024 call volume — About 6 million.
How did AI enter 988? It does not auto-respond directly. A human counselor is always the first to engage. AI's role is limited to two things.
- Call routing — Analyze the caller's first message and route to a suitable specialist (LGBTQ+, veterans, Korean speakers, etc.).
- Counselor assistance — Automatically suggest resources (local ERs, follow-up) the counselor can reference during the call.
Trevor Project (specializing in LGBTQ+ youth, founded in 1998) adopted AI earlier. It built a TrevorBOT simulation that trains new counselors. The AI plays the role of a youth in suicidal crisis, and the new counselor practices responding to it.
The core principle. AI does not replace crisis counselors. It only assists their training and decision-making.
Chapter 16 · The Trend of Using LLMs as Stand-In Therapists
The biggest shadow is elsewhere. The trend of users using ChatGPT, Claude, and Gemini as stand-in therapists.
According to a usage-pattern analysis OpenAI published in late 2024, "emotional support" and "human-relationship advice" rank in the top five non-coding use cases of ChatGPT. Communities like r/ChatGPT and r/Claude post weekly stories such as "one hour with ChatGPT helped me more than four years of therapy."
Pros — free (or 20 USD/month), 24-hour, anonymous, no judgment, infinite patience.
Risks — inaccurate detection of crisis signals, hallucinations about medications, no security or privacy, dependency, no clinical accountability.
OpenAI has built a safety layer into ChatGPT that detects suicide and self-harm signals and points to crisis lines like 988 (US). Anthropic has applied similar guardrails in Claude. But it's not perfect.
The APA's January 2025 statement — "Using a clinically unvalidated LLM as first-line care is dangerous. It can serve as an assistive tool, but it cannot replace a human therapist."
Chapter 17 · AI Hallucinations and Mental Health — Getting Medications Wrong
The most serious mental health risk from LLMs is hallucination about medications.
- SSRIs (selective serotonin reuptake inhibitors) — Sertraline, Fluoxetine, etc. Effect onset in 4-6 weeks; abrupt discontinuation is dangerous.
- Benzodiazepines — Xanax, Ativan. Dependency risk; interactions with alcohol are deadly.
- MAOIs — Risk of food interactions (tyramine).
If you ask ChatGPT or Claude something like "Can I take drug X and drug Y together?", you get an answer. Sometimes it is accurate, but the risk of hallucination is real.
A 2024 study reported that GPT-4 got about 15-20 % of 100 questions on psychiatric drug interactions wrong. Errors are especially common for new drugs (released after 2023) or rare combinations.
A fatal example — if an LLM simply answers "yes" to "Can I take Wellbutrin together with an SSRI?", there is a risk of serotonin syndrome. The correct answer is "consult a doctor," and doctors themselves prescribe carefully.
The rule. Don't ask LLMs about medications. Ask doctors, pharmacists, UpToDate, or Lexicomp. LLMs are for emotional support only.
Chapter 18 · FDA Authorization of AI/ML Mental Health Devices
The FDA began authorizing digital therapeutics (DTx) in 2018.
- Pear reSET, reSET-O (2017-2018) — Substance-use disorder treatment. The parent company went bankrupt in 2023.
- Akili EndeavorRx (2020) — An ADHD video game. Clinical effectiveness is controversial.
- Woebot (2021, 2022 Breakthrough Designation) — Depression, postpartum depression.
- Limbic Access (UK NICE evaluation) — Deployed in the UK NHS.
In 2024, the FDA updated its AI/ML Software as a Medical Device (SaMD) guidance. Two core points.
- PCCP (Predetermined Change Control Plan) — Even when AI models are updated, re-authorization is not required for changes that stay within a predefined scope.
- GMLP (Good Machine Learning Practice) — Mandates data diversity, bias measurement, and monitoring.
The problem is insurance coverage. Even with FDA authorization, the US CMS (Medicare and Medicaid) and private insurers have to assign codes before doctors can prescribe and bills can be filed. CPT codes for DTx have only been partially added starting in 2025, and the coverage scope is narrow.
Chapter 19 · The APA's Position — An Ethics Guide for AI Therapy
The APA (American Psychological Association) issued its first official guideline on AI mental health tools in January 2025.
The five core principles.
- Tools without clinical validation must not claim to provide "therapy." Wellness and support are allowed. Therapy and treatment are restricted.
- Crisis-signal response must be validated. Detection of suicide and self-harm messages plus appropriate crisis-line routing.
- Data privacy must be guaranteed. HIPAA compliance or equivalent protection.
- Users must be told they are talking to an AI. A direct lesson from the Koko incident.
- Protection for vulnerable populations — Additional safeguards for minors, people with prior suicide attempts, and those with severe mental illness.
The APA guideline has no legal force. But it increasingly affects how insurers and enterprise EAPs choose their tools.
The UK's NICE (National Institute for Health and Care Excellence) is stricter. It requires RCT evidence for NHS adoption. Wysa and Limbic have passed that gate.
Chapter 20 · Korea's Mental Health AI — Mindcafe, Trost, SimSimi, Mauumchaengim
Korea has held the top OECD suicide rate for 18 years. Because the social stigma around mental health is strong, the culture of avoiding psychiatric consultation persists. Digital tools have taken root in that gap.
- Mindcafe (mindcafe.co.kr) — Huumart Company. Anonymous counseling matching and self-help groups. Two million cumulative users in 2024. Rolling out AI triage.
- Trost (trost.co.kr) — Trost Inc. Text, phone, and video counseling. Expanded to Japan in 2025.
- SimSimi — Another service from Huumart Company. Not a mental health claim — a chat friend. A Korean-origin global chatbot that surpassed 100 million downloads.
- Mauumchaengim — KAIST industry-academic research. An AI-based chatbot combining meditation and CBT. Beta in 2024.
Since 2024, the Seoul Metropolitan Government has run 1577-0199 Mental Health Crisis Counseling 24 hours a day, and AI-assisted triage is applied to some calls. It developed a Korean-language crisis-signal detection model in partnership with KAIST.
Korean specifics. First, the worry that a record of mental health treatment under national insurance can lead to insurance or employment disadvantages is strong, creating high demand for anonymous chatbots. Second, integrating the suicide-crisis lines — 1393 (suicide prevention), 129 (health and welfare), 1577-0199 (mental health) — is frequently discussed.
Chapter 21 · Japan's Mental Health AI — awarefy, Mentally, TalkMore Japan, NTT R&D
Japan's suicide rate is also the highest in the G7. Suicide is the leading cause of death for youth (ages 15-39).
- awarefy (awarefy.com) — A Tokyo startup. Cybozu has invested. A CBT-based journaling and coaching app. Japanese first.
- Mentally (mentally.jp) — AI chatbot + clinical-psychologist matching.
- TalkMore Japan — Text counseling. Emphasizes anonymity.
- Cotree (cotree.jp) — Japan's BetterHelp. Clinical-psychologist matching plus video counseling.
- NTT Data / NTT R&D — Japanese-language emotion-recognition AI research. Call-center deployment cases.
The Japanese government runs crisis lines like #いのちSOS (#命SOS, "Life SOS") and よりそいホットライン (Yorisoi Hotline). The Tokyo Metropolitan Government also pilots LINE-based counseling.
Japan's specifics — ijime (bullying) and harasumento (workplace harassment) are recognized as major causes of mental health crises. School-use and workplace-use chatbots are separate segments.
Chapter 22 · Privacy — HIPAA, GDPR, K-PIPA, Japan's APPI
Mental health data is among the most sensitive information.
- HIPAA (US) — Protects data handled by healthcare providers and insurers. Consumer mental health apps (Replika, Earkick, Character.AI) are generally not subject to HIPAA. This is a major trap. EAPs like Lyra, Spring, and Modern Health are subject to HIPAA.
- GDPR (EU) — Mental health data is Special Category Data (Article 9). Explicit consent plus clear specification of processing purpose are required.
- K-PIPA (Korea) — Personal Information Protection Act. Sensitive information (Article 23) includes mental health. Explicit consent plus pseudonymization.
- Japan's APPI — A structure similar to Korea's PIPA. Strengthened by the 2022 revision.
The BetterHelp FTC settlement (2023, 7.8 million USD) is a major signal. Data from free-to-use mental health apps may be used for ad targeting. With free apps like Replika and Earkick you have to read the terms carefully.
Practical recommendations.
- Prefer apps that store mental health data anonymously in the cloud.
- Confirm there is explicit wording in the terms saying "we do not use data for advertising."
- For company EAPs, HIPAA must apply, and the company must not be able to see whether an individual employee uses the service.
Chapter 23 · A Comparison Table of AI Mental Health Tools
[CBT chatbots — strong clinical evidence]
Woebot B2B only (B2C ended 2024) FDA Breakthrough Device
Wysa Free + 99 USD/year NHS, 50 countries, 50+ RCTs
Iris Free Partial CBT borrowing
[Mood trackers + GPT]
Earkick Free + 40 USD/year Gen Z, voice input
awarefy (Japan) Free + ~1,000 JPY/month Japanese CBT journal
[AI companions]
Replika Free + 70 USD/year (Pro) EROS-mode controversy
Character.AI Free + 10 USD/month Lawsuit, FTC probe
Pi Free Effectively shut down
Xiaoice/Rinna Free Huge in China and Japan
[Meditation + AI]
Headspace + Ebb 13 USD/month Follows APA guideline
Calm 15 USD/month Conservative AI integration
[Enterprise EAP]
Lyra Health Company-paid HIPAA, human-first
Spring Health Company-paid Precision matching
Modern Health Company-paid Coaching + human therapists
[Telehealth + AI triage]
Talkspace From 70 USD/week Some insurance
BetterHelp From 65 USD/week 2023 FTC settlement
[Crisis lines + AI assist]
988 (US) Free Humans first
Trevor Project Free LGBTQ+ youth
1393 (Korea) Free Suicide prevention
#いのちSOS (Japan) Free LINE also available
Chapter 24 · User Decisions — Which Tool, When
[Mild symptoms — daily management]
→ Mood trackers: Earkick, awarefy, Calm journals
→ Meditation: Headspace, Calm
→ CBT chatbot: Wysa (in Korea/Japan if English is OK)
[Moderate symptoms — help is needed]
→ Human counseling + AI triage: Talkspace, BetterHelp
→ Korea: Mindcafe, Trost
→ If the company provides EAP: Lyra, Spring, Modern Health (US)
[Severe symptoms — expert care needed]
→ Psychiatric care. Medication + human 1:1 therapy
→ Chatbots only as adjuncts (emotion logging, meditation aid)
[Crisis — suicidal or self-harm impulses]
→ Korea: 1393 (suicide prevention), 129 (health and welfare)
→ US: 988 (Suicide & Crisis Lifeline)
→ Japan: #いのちSOS, よりそいホットライン
→ Never rely solely on LLMs or chatbots
The core principle. AI is strong at the daily management of stages 1-2. For stages 3-4, humans are the core and AI is the assistant. Stage 4 (crisis) is the sole responsibility of human counselors and emergency rooms.
Chapter 25 · Outlook for the Next Five Years — Where It Is Heading
The major currents over the next five years as of May 2026.
- The clinical-validation gap narrows — As more clinical RCTs come out for Wysa- and Woebot-class tools, insurance coverage expands.
- Crisis-signal detection models get standardized — APA, NICE, FDA, Japan's MHLW, and Korea's MFDS may build validation standards for crisis-signal detection.
- More lawsuits — Character.AI's case is the first. Damage claims when unvalidated AI mishandles a mental health crisis will grow.
- EU AI Act applies — Took effect in 2024. Mental health AI can be classified as "high-risk." Additional obligations to enter the EU market.
- LLMs as primary entry channel — ChatGPT, Claude, and Gemini cannot refuse the stand-in-therapist role. The direction is to harden safety guardrails.
- Hybrid care as standard — A package combining human therapist + AI assistant + mood tracker + meditation becomes the insurance standard.
Risk areas. Protection of minors — The Character.AI incident will not be the last. The likelihood of stronger regulation of AI companions for minors in the US, EU, and Korea.
Chapter 26 · A Self-Check — Choosing Safe Tools
Seven questions to ask when choosing an AI mental health tool.
1. Does this app say "therapy" or "support"?
→ If it says "therapy" without FDA or NICE validation, be suspicious.
2. How does it respond to crisis signals?
→ Confirm in the terms that suicide and self-harm messages immediately surface a crisis line.
3. Is there RCT evidence?
→ Wysa and Woebot have it. Earkick and Replika do not.
4. Is data used for advertising?
→ Read the terms especially carefully for free apps. If wording like "used for ad targeting" appears, avoid.
5. Which LLM does it use?
→ GPT-4, Claude, an in-house model? Are there custom guardrails?
6. Does it disclose that it is an AI?
→ Apps that openly call themselves "AI companions" are safer. Lesson from Koko.
7. For minors, are there guardian consent and additional filters?
→ This area has been strengthened after the Character.AI incident.
If the app fails three or more of these seven, do not use it as a mental health tool. For light uses such as a mood journal it may be fine, but never rely on it in a crisis.
Epilogue — AI Does Not Replace Human Therapists
The map this essay has drawn is dense with about fifty tools. Woebot, Wysa, Earkick, Replika, Character.AI, Headspace Ebb, Lyra, Talkspace, 988, 1393, Mindcafe, awarefy. Each has its own meaning in its own place.
But the central truth about mental health AI in 2026 is this. AI does not replace human therapists. AI lowers entry barriers and expands access.
May the Character.AI incident not be the last warning. The grief Sewell Setzer's family carries cannot be filled by any data. The reason the APA, FDA, NICE, Korea's MFDS, and Japan's MHLW are tightening guidelines is to reduce that kind of tragedy.
If you have read this far, decide one thing today. Write down the number of a crisis line you would call when you or your family struggle. Korea 1393, US 988, Japan #いのちSOS. That single line might save someone's life a year from now.
A good tool, a good therapist, a good friend. AI is only a bridge that connects the three.
Appendix · A Quick Reference of Crisis Lines
[Korea]
Suicide prevention line 1393 24h, free
Mental health crisis 1577-0199 24h
Health and Welfare 129 24h
Youth line 1388 24h
[US]
988 Suicide & Crisis 988 24h, voice / text / chat
Trevor Project 1-866-488-7386 (LGBTQ+ youth)
Crisis Text Line HOME → 741741
[Japan]
Inochi no Denwa 0570-783-556
Yorisoi Hotline 0120-279-338 24h, free
#いのちSOS 0120-061-338
[EU and others]
UK Samaritans 116 123 24h
International IASP list iasp.info/resources/Crisis_Centres/
References
- Woebot Health
- Woebot FDA Breakthrough Device Designation (Postpartum)
- Wysa
- Wysa NHS Deployment
- Earkick
- Replika
- Replika EROS Mode Restoration Coverage (Vice)
- Character.AI
- Character.AI Lawsuit Coverage (NY Times)
- Koko GPT-3 Experiment Coverage (NBC News)
- Headspace Ebb Launch
- Calm
- Lyra Health · Spring Health · Modern Health
- Talkspace · BetterHelp
- 988 Suicide and Crisis Lifeline
- Trevor Project
- APA Statement on AI in Mental Health (2025)
- FDA AI/ML SaMD Action Plan
- BetterHelp FTC Settlement (2023)
- Mindcafe
- Trost
- SimSimi
- awarefy
- GDPR Article 9 (Health Data)
- PIPA Korea Personal Information Protection Commission
- Japan APPI (PPC)
- Cornell-MIT ChatGPT Loneliness Study (2025)
- WHO Mental Health and COVID-19